Palvella Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Feb '25 Feb 21, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	-1.43	-2.08	-1.40
Quick Ratio	1.86	3.11	2.78
Current Ratio	2.14	3.20	2.86
Return on Assets (ROA)	-	-61.63%	-
Return on Capital (ROIC)	-	-110.58%	-
Buyback Yield / Dilution	-0.02%	-1.36%	-
Total Shareholder Return	-0.02%	-1.36%	-

Source: S&P Capital IQ. Standard template. Financial Sources.